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The MRC OX-34 mouse mAb was raised against rat T blasts and was found
to label all T lymphocytes and most thymocytes but not B lymphocytes (1) . The
OX-34 antigen had an apparent mol wt of 50,000 (1), and it seemed possible
that it was the rat equivalent of human CD2 (T11) antigen (2-4). However, 0X-
34 mAb labeled many more cells in rat spleen than could be accounted for by T
lymphocytes (1), a property not described for human CD2 (2-4).
To further establish the nature of the OX-34 antigen, purification and molec-
ular cloning was carried out, to yield the protein sequence. The expression of
antigen in the thymus and spleen was also further investigated. The results show
that OX-34 is rat CD2 and that the molecule is expressed in the T lymphoid
lineage and on spleen macrophages. Comparison of the sequence with that of
other antigens shows a highly significant relationship with CD4 antigen.
Materials and Methods
Animals.
￿
PVG/c and AO inbred rats were maintained in the SPF Unit of the MRC
Cellular Immunology Unit. Sprague-Dawley rats were from Harlan Olac Limited, Bicester,
United Kingdom .
Monoclonal Antibodies.
￿
MRC OX-34, IgG2a, anti-rat CD2 (1); MRC OX-35and MRC
OX-38, non-competing mAbs against rat CD4 (W3/25) (1); MRC OX-8, anti-rat CD8
(5); MRC OX-19, anti-rat CD5 (Ly-1) (6); MRC OX-12, anti-rat K chain (7); ED3, anti-
rat tissue macrophages (8) were provided by Dr. C. D. Dijkstra, Free University, Amster-
dam, The Netherlands. MRC OX-21, anti-human C3b INA was used as a negative
control.
Purification of OX-34 Antigen.
￿
Methods were as described previously (9). Purification
was from deoxycholate extracts of rat thymocyte membranes that had been stored frozen
after use in previous antigen purifications. Material from ^"2.5 X 10'2 thymocytes was
passed through a 5-ml MRC OX-34 IgG affinity column (5 mg IgG/ml Sepharose 4B
CL). The column was washed with deoxycholate buffer and then with pH 11 .5 buffer
without eluting the antigen. This was recovered by a second elution with 0.5 M propionic
acid in the absence ofdetergent. Recovery ofantigenic activity was measured by inhibition
ofan indirect radioactive binding assay (9).
Protein Chemistry. Standard methods were used: analysis by PAGE in SDS (1) on a
Mighty Small gel apparatus (Hoefer Scientific Instruments, San Francisco, CA); reduction
and alkylation of antigen with '4C-iodoacetic acid (10, 11); tryptic digestion; gel filtration
of peptides on Biogel P30 in 0.1 M NH4HCOs; reverse-phase HPLC for peptide purifi-
cation; amino acid analysis of protein and peptides (11). NH2-terminal and peptide
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sequencing was on an Applied Biosystems, Inc., (Foster City, CA) gas phase sequencer or
a Beckman Instrument, Inc., (Fullerton, CA) spinning cup sequencer with PTH amino
acids detected by HPLC.
Nucleic Acid Chemistry.
￿
Oligonucleotide synthesis was by the phosphodiester method
(12) and rat thymocyte cDNA libraries were prepared by the RNAse H method (13).
Cloning ofcDNA was by standard methods (14) as used in previous studies (15). Sequenc-
ing was by the M13 method (16) and sequence analysis was via the programs of Staden
(17). For statistical analysis of sequence the Align program was used (18). The scores were
based on the Mutation Data Matrix (250 PAMS) with a bias and gap penalty of six. 150
random runs were used for all comparisons except the short sequences in Fig. 3c, for
which the number was 100.
Analysis of Antigen Distribution.
￿
Labeling of lymphoid cell populations involved incu-
bation with tissue culture supernatant containing MRC OX-34 mAb followed by purified
fluorescein F(ab')2 anti-mouse IgG antibody with analysis on a FACS flow cytometer
(Becton Dickinson & Co., Mountain View, CA) (19). Rosette depletion of thymocytes with
MRC OX-8, OX-35, and OX-38 was carried out using the method of Mason (19). Labeling
of tissue cryostat sections was by the immunoperoxidase method (20) counterstained with
Harris' hematoxylin. Acid phosphatase was detected by histochemistry as described
previously (21) with modifications; 0.1 M sodium cacodylate buffer (pH 5) rather than
Michaelis veronal acetate buffer, naphthol AS-BI phosphate was the substrate, incubation
was for 40 min at 37'C.
Results
Purification of OX-34 Protein.
￿
OX-34 antigenic activity was substantially de-
pleted from the detergent extract of rat thymocyte membranes after passage
through the OX-34 affinity column, but the retained activity eluted very poorly
(1% yield) with a pH 11 .5 buffer in deoxycholate. Thus elution with 0.5 M
propionic acid without detergent was tried and this gave a recovery of ^-40% of
the applied antigenic activity. The purified material is shown in Fig. 1 A where
one broad band is seen. By amino acid analysis, 1 mg of protein was recovered
and this is a reasonable amount from 2.5 X 10' 2 cells given that 17,700 molecules
of MRC OX-34 mAb are bound per Sprague-Dawley thymocyte (22) and that
the antigen yield from cells to detergent extract is usually ^-70% (9).
The material in Fig. 1 A shows a diffuse band with a leading edge of 42,000
apparent mol wt. This is less than the mol wt of 50,000 determined for OX-34
labeled at the cell surface with ' 251, and it seems likely that the material in Fig.
1 A is partially degraded. The amino acid analysis is shown in Fig. 1 B, and from
this and the protein sequence below it seems likely that much of the cytoplasmic
domain has been lost. We draw this conclusion since proline is concentrated in
the cytoplasmic tail (Fig. 3B) and the percentage for Pro from the sequence is
10%, while the value by analysis from the purified protein is only 3.9% (Fig.
1 B).
Protein and Peptide Sequence. ^-20 nmol OX-34 protein was reduced and
alkylated and 18 nmol was digested with trypsin for peptide purification while 2
nmol was subjected to NH2-terminal sequencing (Fig. 1 A). Peptides were purified
by gel filtration and reverse-phase HPLC and were selected for sequencing on
the basis of their amino acid analysis. Peptide 2 was chosen as a candidate for
oligonucleotide probe sites while peptide 1 was sequenced because ofthe presence
of glucosamine in the analysis (see legend to Fig. 1). Peptide 3 was sequenced to
confirm the predicted sequence after the transmembrane segment. All the370
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FIGURE 1.
￿
Analysis of OX-34 antigen and peptide sequences . (A) 2 .5 ug of purified OX-34
antigen electrophoresed on a 12% polyacrylamide gel in SDSand stained with Coomassie blue.
(B) Amino acid analysis (residues per 100 amino acids) derived from duplicate analyses of 10
ug of OX-34 antigen after oxidation with periodic acid and hydrolysis for 24 h at 110°C with
5.7 N HCl and 0.01 M phenol . Destruction of Serand Thr was not corrected for, and Trp
was not detected . The analysis from purified antigen is compared with that calculated from
the sequence in Fig. 3B . (C) Protein sequences. TheNH2-terminal sequence was determined
from 2 nmol ofreduced and alkylated antigen in the gas phase sequencer . At the first position
many anomalouspeaks were seen when the PTH amino acid derivatives were run on HPLC
and no residue could be assigned (the same result was obtained on a second run with unreduced
antigen) . After that, one residue was clearly assigned at each position through to Ala at residue
40, with the exception of positions 31 and 34 where no residues were detected (these were
later found to be Arg residues from the cDNA sequence) . The yield at Asp 2 was 350 pmol
and the repetitive yield was 97% . The peptide sequences were determined on the Beckman
Instruments, Inc ., spinning cup sequencer from 4, 6, and 7 nmol of peptides 1, 2, and 3,
respectively . The initial and repetitive yields were : peptide 1, 1 .6 nmol, 95%; peptide 2, 3.1
nmol,90% ; peptide 3, 5 nmol, 92% . All the assignments were unambiguous with the exception
of the positions shown in brackets, at which no residue was detected . The bracketed residues
were assigned from amino acid compositions as follows, with all residues not given showing
<0.2 mol/mol peptide . (Peptide 1) Asp (3.7), Thr (3.4), Ser (2), Gly (1 .7), Val (2.2), Tyr (1 .4),
Arg (1), glucosamine (5.4). (Peptide 2) Cys (2), Asp (2), Thr (2 .8), Ser (2.2), Glu (5 .2), Pro
(0.9), Gly (1.2), Ala (1 .5), Val (2.8), Met (1.5), Ile (1 .6), Leu (3.5), Phe (0 .9), Lys (2), glucosamine
(3.3). (Peptide 3) Ser (0 .5), Glu (2.9), Gly (1 .1), Ile (0 .9), Leu (1), Lys (1) . In peptides I and 2
glucosamine was detected in good yield even though peptide hydrolysis conditions were used
and the amounts indicate the presence of 2 and 1 N-linked carbohydrate structures in each
case . These are assigned to Asn residues at positions 7 and 14 in peptide 1 and residue 16 in
peptide 2 . Glycosylated residues are not detected in the sequencer run .WILLIAMS ET AL .
￿
371
FIGURE 2 .
￿
RatCD2 cDNA clones and nucleotide sequence. (A) restriction enzyme sites used
in sequencing are shown and the arrows indicate the sequences that were determined. (B) the
combined nucleotide sequence is shown with the stop codon underlined . The dot above residue
211 indicates a position that differed in the two clones (see text) . The arrows indicate positions
where the poly(A) tails started in each clone .
peptides gave unambiguous sequences, which agreed with the amino acid com-
positions given in the legend to Fig . 1 . In the NH2-terminal sequence the first
residue was not determined due to multiple peaks at this position . At other
positions residues could be clearly assigned .
cDNA Cloning .
￿
Two anti-sense-mixed oligonucleotide probes were synthe-
sized on the basis of the sequence of peptide 2 . The peptide sequences used
were : KPMIYW to give 17 nucleotides containing a total of 48 sequences, and
MIYWEC to give 17 for 12 . In primary screening of a rat thymocyte cDNA
library the lower redundancy probe was used first and possible positives were
checked by a second screen with the other probe . From a library with a
complexity of 60,000, eight colonies were picked and one of these, pRCD2-1,
was correct. This cDNA clone was not full length and thus other libraries were
screened with pRCD2-1 cDNA labeled by nick translation . The positive clones
were rescreened with either of the oligonucleotides above, plus another contain-
ing 14 nucleotides at a redundancy of 8, which was predicted from the sequence
NFQMT beginning 20 residues from the NH2-terminus (Fig . 1 C) . In this way
the cDNA clone pRCDR2-6 was isolated from a rat lymph node cDNA library;
the relationship of this to pRCD2-1 is shown in Fig. 2. The sequence predicted
from pRCD2-6 was still not full length, but as expected overlapped with the
NH2-terminal protein sequence (see below) .
Nucleotide and Predicted Protein Sequence .
￿
The nucleotide sequencing strategy
is shown in Fig. 2A and all bases were determined by sequencing in both
directions such that each position was determined, on average, 5 .5 times . An
open reading frame was found in both pRCD2-1 and PRCD2-6 and the only
difference between the two clones in this region was a guanine at nucleotide 211372
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in pRCD2-1 vs. adenine in pRCD2-6 (Fig. 2). This leads to a coding difference
of Asp vs. Asn at amino acid 90 (Fig. 3). Both libraries were constructed from
AO strain rats but not from the same colony, and thus the difference could be
due to a polymorphism or alternatively to a sequence change occurring during
cDNA synthesis.
The two clones had poly(A) tails in different positions after extremely short
3' noncodingregions(Fig. 2B). The poly(A) tailsstarted at 47 and 26 nucleotides
after the last coding nucleotide for pRCD2-1 and pRCD2-6, respectively. The
poly(A) addition signals are presumably thesequences AATAAA and ATTAAA
starting at 26 and -2 nucleotides after the last coding nucleotide (23). Neither
clone contained 5' sequence extending to a predicted leader sequence, but the
protein sequence predicted from Fig. 2 overlaps with the NH2-terminal protein
sequence (Fig. 1) to yield the full protein sequence, except for the first residue
as shown in Fig. 3.
The peptide and NH2-terminal sequence given in Fig. 1 fitted exactly with the
predicted protein sequence from the cDNA shown in Fig. 3B and established
the sequence as correct until amino acid 223. The predicted protein sequence
shows a very hydrophobic stretch of amino acids at residues 178-206, and this
is likely to span the membrane. The sequence NH2-terminal to the hydrophobic
piece is likely to be extracellular because it includes four N-linked carbohydrate
sites (Fig. 3B), three of which are known to be glycosylated from the peptide
data (Fig. 1). A glycopeptide accounting for the fourth site has not yet been
isolated. The cytoplasmic domain is likely to start with the cluster of basic
residues after the hydrophobic sequence and is unusual, with Pro accounting for
26 of 116 positions.
Comparison with other Sequences.
￿
Comparison of the OX-34 sequence with
that for human CD2 as determined by Sewell et al. (24) established that OX-34
is rat CD2. Overall the sequences were 56% identical, and a notable feature was
the findingthat a blockof24 residues in the cytoplasmic domain ofeach sequence
was identical (sequence 287-310 in rat CD2). Apart from the biological interest
of this, these identities prove that the putative cytoplasmic domain is correct in
spite of the fact that peptides corresponding to this region were not isolated. In
the pure antigen it seems likely that this part of the sequence has been lost by
proteolysis that may have occurred during successive freezing and thawing of
the detergent extracts from which the antigen was isolated, even though inhibi-
tors of proteolysis were added.
Comparison of the rat CD2 sequence with those ofother cell surface antigens
showed highly significant matches with rat and human CD4 antigen sequences.
The relationships are shown schematicallyin Fig. 3A andas analignmentbetween
rat CD2 and rat CD4 in Fig. 3B. The significance of the alignment was tested
using the Align program, which scores the best match for the test sequences and
then compares this score with a mean maximal score from a chosen number of
comparisons using sequences compiled from the test sequences after randomi-
zation. The score for the real sequences is given as SD unitsaway from the mean
random score, and the significance ofthese can be roughlyjudged from relation-
ships between the probability of a chance result and SD scores as follows:
probability 10-2, SD score 2.3; 10-3, 3.1; 10-5, 4.3; 10-7, 5.2; 10-9, 6.0 (referenceA
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FIGURE 3.
￿
Sequence of CD2 and comparison with CD4. (A) Shows schematically the align-
ments ofCD4and CD2 sequences with regions that were compared in statistical analysis using
the Align program. The positions of disulphide bonds are based on data from mouse CD4
(33). (B) Rat CD2 aligned with the second half of rat CD4 (25) with the CD2 sequence
continuing on after the last CD4 residue (182-430). Thealignments are as givenby theAlign
program and identical residues are boxed. Dashes indicate gaps inserted to maximize the
similarities. Asterisks indicate N-linked glycosylation sites in rat CD2 and the line under the
sequence at CD2 residues 181-205 indicates stretches of hydrophobic sequence common to
both molecules. The unknownresidue at position one ofCD2 is indicatedasX.(C) Alignments
ofCD2 residues 63-82with V domainsand V-relatedsequencesaround theconserved000H-
terminal Cys of Ig or Ig-related domains plus two sequences selected as controls on the basis
that they had the DSGXY pattern that initially drew attention to this section of CD2. The
sequencesareas follows with theNBRF data base number (reference 26)or literature reference
given in parentheses. CD4C2 and CD4C4, human CD4 around Cys 86 and 161, respectively,
(34), Thy-1, mouse Thy-1.1 (TDMS); PIGRI, rabbit poly(Ig) receptor domain I [QRRBG];
CD8I1, 37-kD chainratCD8 (35); TCR y, T receptor Vy [RWMSVBJ; RABV, rabbit Ig VN
[HVRBP3];V,EU,human Ig V, myeloma EU [KIHUEV];VX NIG48, human Ig VX myeloma
NIG48 [L6HU48]; FIBRINO, fibrinogen -1 chain precursor [FGLMGS]; THYRO, thyroglob-
ulin precursor [UIHU]. (D) Alignment of rat CD2 domain 1 with human CD4 domain 1 as
givenby the Align program. Boxes show identical residues and gaps are shown by dashes.
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18). For comparison 1 as shown in Fig. 3A, the score for rat CD2 vs. rat CD4
and human CD4, respectively, was 7.7 SD and 6.8 SD; for comparison 2 the
values were 7.9 SD and 6.9 SD; and for comparison 3 they were, respectively,
2.1 SD and 2.3 SD. From this we conclude that there is a very strong case for a
relationship between CD2 and CD4 in the membrane proximal domain and
transmembranesequence, but that the match ofCD2 domain 1 and CD4 domain
3 is only weakly statistically supported even though some sequence similarities
are evident by eye.
Elsewhere it has been argued that domain 3 of CD4 is Ig-related even though
it lacks a disulphide bond (25), and domain 1 of CD2 is also of interest in this
regard. Within CD2 domain 1, the sequence at residues 63-82 is highly similar
to sequences ofIg V- or V-like domains around the COON-terminal Cys of the
conserved disulphide bond (Fig. 3 C), even though the CD2 sequence has no Cys.
The similarity is such that when the NBRF data base (26) was searched with this
sequence using the FASTP program (27), 16 of the top 20 matches were with
Ig or Tcr V domains or other V-related sequences (data not shown). The
significance of the match can also be judged by the matrix of Align scores for
the short sequences in Fig. 3C. The scores for the CD2 sequence vs. the V- or
V-related sequences are extremely good when related to the scores obtained
within the Ig-related sequences or to the scores for two control sequences. The
controls were selected by searching the NBRF data base for sequences with the
peptide DSGXY, which is amajor partofthe V-like pattern that initially indicated
that the CD2 sequence residues 63-82 may be Ig-related. In addition to this, the
whole of CD2 domain I can be aligned with domain 1 of CD4 (which is clearly
Ig-related) toshow asignificant overall relationship (Fig. 3D), includingthe short
patch of sequence shown in Fig. 3C. The Align score for the alignment shown
in Fig. 3D (human CD4) is 3.2 SD, while for rat CD4 the score was 1 .7 SD. In
the same region human CD2 gave scores of 3.4 and 5 for rat and human CD4
respectively. Taken together, these scores provide good evidence that CD2
domain 1 is related to domain 1 of CD4 and also to Ig-V domain sequences,
even though it lacks the conserved Cys residues of typical Ig-like domains.
Cellular Expression of OX-34 Antigen.
￿
In humans, CD2 antigen has been
reported (28) to be expressed only on thymocytes, Tlymphocytes, and NK cells,
and in the T lineage the antigen is expressed at an early stage. Expression of
OX-34 in the rat T cell lineage was examined and the results are shown in Fig.
4. 60% oflymph node cells were labeled (Fig. 4A) and overlap experiments with
other markers established that the OX-34' cells included all T cells (1). Most
thymocytes were positive, albeit with weak labeling for some cells (Fig. 4B). Only
2-4% of bone marrow cells showed labeling above control values (Fig. 4C).
Peripheral T cells stained more intensely than the majority of thymocytes;
however, CD4-,CD8- thymocytes, which include the rat thymocytes that are
active in thymopoiesis (29), are split into two sets by OX-34, with 59% of the
cells showing clear labeling of a similar intensity to peripheral T cells. The rest
were unlabeled or very weakly labeled (Fig. 4D).
In preliminary studies (1), MRC OX-34 was found to label many non-T cells
in spleen sections and this is shown in Fig. 5a. The position of T cells in the
spleen was established by labeling with OX-19 mAb (anti-CD5 [Ly-1]) (Fig. 5c).WILLIAMS ET AL .
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FIGURE 4 .
￿
Labeling of lymphoid cells with MRC OX-34 mAb . Cells were labeled with 0X-
34 mAb in theform of tissue culture supernatant, followed by fluorescein F(ab')2 anti-mouse
IgG, with both steps at 4°C . Fluorescence histograms were obtained on a Becton Dickinson &
Co. FACS II with 106 cells analyzed for each profile and with cell number shown on a linear
scale . CD4-,CD8- thymocytes were prepared by rosette depletion . Labeling with MRC 0X-
21 mAb is shown as a negative control for each cell type (dotted line) .
The non-T OX-34+ cells are prominently seen in the marginal sinus, the
marginal zone, and the red pulp . The pattern of non-T cells was very similar to
that shown by the ED3 macrophage marker (8) (Fig . 5 b) . To establish whether
these cells were macrophages, sections were double labeled for the acid phospha-
tase macrophage marker and OX-34 antigen . Fig . 5, e-gshow, respectively, 0X-
34 labeling, acid phosphatase labeling, and double labeling . When the double-
labeled sections were studied under the microscope there was no doubt that the
large cells in the marginal zone were labeled by OX-34 mAb and were acid
phosphatase-positive . This was also likely to be the case for cells in the red pulp,
but the interpretation was more difficult since individual cells were not clearly
defined .
In previous studies (1) it was found that OX-34 mAb did not label peritoneal
macrophages that were CD4+ . In this study, liver macrophages were also found
to be OX-34- in comparison with clear-cut labeling with anti-CD4 mAbs (Fig . 5,
h and i) .
It could be argued that labeling of spleen macrophages with OX-34 is due to
an irrelevant crossreaction, and to check this, new anti-rat CD2 mAbs are being
raised after immunization with pure OX-34antigen . OnenewmAbthat competes
with OX-34 in binding to cells has been isolated thus far and this gives the same
labeling pattern in the spleen as OX-34 mAb.
Discussion
The OX-34 antigen has been purified and cDNA clones have been obtained
to yield the sequence of the fully processed molecule, with the exception of
residue 1 . Comparison with the sequence of human CD2 (T11) antigen (24)
showed that OX-34 is ratCD2 (data not shown) . The sequence has a number of
interesting features and is notable for a cytoplasmic domain of 116 residues,
which is considerably larger than that of many other molecules of the T
lymphocyte surface. It was particularly interesting that a segment of 24 residues
in the cytoplasmic domain was identical between rat and human sequences and
thus may represent a binding domain for a cytoplasmic enzyme or structural
element .
The rat CD2 sequence showed clear-cut matches with CD4, and the signifi-
cance of these similarities can be summed up by the fact that the Align scoresFIGURE'5 .
￿
Distribution of OX-34 antigen in spleen and liver . Frozen sections of spleen were
stained using theimmunoperoxidase technique with mAbs : (a)MRC OX-34, (b) ED3, (c) MRC
OX-19, (d) MRC OX-21 . T, T cell area, B, B cell area, MZ, marginal zone, RP, red pulp . (e-
g) High power micrographs of the marginal zone and red pulp are shown . (e) MRC OX-34
immunoperoxidase, (f) acid phosphatase histochemistry, (g) MRC OX-34 plus acid phospha-
tase . Open arrows, T cells . Closed arrows, large cells identified as macrophages. Frozen sections
of liver were stained using the immunoperoxidase technique with mAbs (h) MRC OX-35 and
MRC OX-38, (i) MRC OX-34, and (j) MRC OX-21 .
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for the segment of ^-100 residues in Fig. 3A (comparison 2) are at about the
same level as is obtained for various Tcr vs . Ig V domain comparisons .
Is CD2 a member of the Ig superfamily? TheCD2 membrane proximal region
closely matches CD4 domain 4, with the Cys residues at 117 and 157 being in
positions equivalent to the Cys residues that form the third disulphide bond in
CD4. In an analysis of CD4 sequences (25) it has been argued that domains 1-4
as shown in Fig. 3A were all originally derived from Ig-related domains, and if
this is accepted then CD2 should be seen as another of the Ig-related molecules .
In the current analysis, evidence is presented for a relationship between domains
1 of CD2 and CD4, and this provides a further link to the Ig-related sequences
since CD4 domain 1 has strong similarities to Ig V domains. Domain 1 of CD2
is also identified as a second sequence, in addition to domain 3 in CD4, that may
be Ig-related and possibly folded like a V domain without the presence of the
conserved disulphide bond .
Similarities between CD2 and CD4 were seen in cellular expression as well as
structure . CD2 appears to be on all rat thymocytes and T lymphocytes with the
exception of ^-40% of CD4-,CD8- thymocytes, and this is consistent with the
finding that CD2 is expressed early in the human T lymphocyte lineage . In the
rat it will be interesting to see whether or not thymopoiesis can be given by the
two subsets of CD4-,CD8- cells that are marked by OX-34 mAb (Fig . 4) . The
CD4 antigen is expressed a little later than CD2 in the T cell lineage and is
ultimately found on a clear subfraction of peripheral T cells that are all CD2' .
Both antigens are also found on rat macrophages (1, 20); however, in this case,
the CD4 antigen shows a broader macrophage distribution while expression of
CD2 is clearlyon a macrophage subset . The macrophage CD2 expression remains
to be fully investigated but the antigen seems to be present on most spleen
macrophages but absent from peritoneal and liver macrophages . The pattern of
CD2+ macrophages in the marginal zone and the marginal sinus was particularly
striking .
In humans the CD2 antigen has been implicated in two functional aspects .
Mixtures of anti-CD2 mAbs are mitogenic for T cells (30), and it has been
recently suggested (31) that CD2 is a receptor for aT cell growth factor that
plays an important role at an early stage in the T lymphocyte lineage. Other
work (32) provides evidence for a role for CD2 in adhesion reactions between
lymphocytes and other cells . The data in the present paper donot strongly relate
to functional aspects since the OX-34 mAb has no functional effects on prolif-
erative T cell responses . However, the expression of CD2 on macrophages as
well as T cells may be more compatible with the idea that the molecule plays a
role in cell-cell interactions rather than as a growth factor receptor . Clearly,
more data is required and multiple roles for cell surface molecules cannot be
excluded .
Summary
The MRC OX-34 antigen of rat T lymphocytes was purified and peptide
sequences were obtained . Oligonucleotide probes were synthesized and cDNA
clones coding for the antigen were isolated and sequenced to yield a predicted
protein sequence for the molecule that fitted the peptide data . Comparison of378
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this sequence with that for human CD2 determined by Sewell et al . (24) showed
that OX-34 is ratCD2 . The primary structure of the molecule was notable for a
moderately large cytoplasmic domain of unusual sequence and also for its highly
significant relationship to CD4 antigen in the membrane proximal extracellular
region and the transmembrane sequence . A relationship to the Ig superfamily
can be argued for the two extra cellular domains of CD2, even though neither
fits the standard pattern for Ig-related domains.
Within theT lymphocyte lineage, rat CD2 seemed to be present on all stages
with the exception of ^-50% of the thymic CD4-,CD8 - cells . In addition, the
antigen was prominent on most macrophages in the spleen but not found on
peritoneal or liver macrophages . CD4antigen is also expressedonT lymphocytes
and macrophages, and thus CD2 and CD4 appear similar in their cellular
expression as well as structural characteristics .
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W.A. Sewell,M. H. Brown,J. Dunne,M.J. Owen, and M. J . Crumpton foraccess to the
human CD2 sequence ; Mr. Stan Buckingham and Catherine Lee for photography; and
Caroline Griffin for manuscript preparation .
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